Skip to main content

Considerable Gaps Seen in Provision of Effective Treatment for Opioid Addiction

Medically reviewed by Carmen Pope, BPharm. Last updated on July 16, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, July 16, 2024 -- There are considerable gaps in provision of effective treatments for opioid use disorders (OUD) at U.S. substance use disorder (SUD) treatment facilities, according to a study published online July 11 in the Journal of the American Medical Association.

Tae Woo Park, M.D., from the University of Pittsburgh, and colleagues conducted a cross-sectional study of specialty outpatient SUD treatment facilities that treat OUD. The prevalence of available treatments individually and combined was reported. Treatments offered in federally certified opioid treatment program (OTP) and non-OTP facilities were compared.

Overall, 17,353 representatives from SUD facilities were surveyed. OUD treatment was offered at 12,060 outpatient facilities: 1,925 and 10,135 OTPs and non-OTPs, respectively. The researchers found that 99.4 and 55.1 percent of OTP and non-OTP facilities offered medications for OUD (MOUD), respectively, and 35.2 percent of facilities offered psychosocial treatments only. Of the facilities that offered MOUD, a higher proportion of OTPs versus non-OTPs offered any MOUD plus contingency management (53.3 versus 41.6 percent), and a lower proportion of OTPs offered any MOUD, any psychosocial treatment, other SUD treatment, and mental health services (16.7 versus 33.5 percent). Overall, 62.2, 45.6, and 2.0 percent of facilities offered at least one, at least two, and all four MOUD types, respectively. A lower proportion of non-OTPs offered sublingual and injectable buprenorphine compared with OTPs (49.7 versus 83.4 percent; 22.4 versus 26.4 percent); injectable naltrexone was offered at similar rates. OTPs offered contingency management more frequently than non-OTPs (54.1 versus 40.2 percent).

"Substance use treatment facilities reported significant gaps in provision of effective treatments for OUD," the authors write.

One author reported ties to relevant organizations.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted July 2024

Read this next

2019 to 2023 Saw Increase in Prevalence of Psilocybin Use in the United States

TUESDAY, April 29, 2025 -- The prevalence of lifetime and past-year use of psilocybin increased from 2019 to 2023 among all age groups in the United States, according to a study...

Smoking, Eating, Vaping, Dabbing Are Most Common Routes of Marijuana Use

WEDNESDAY, April 23, 2025 -- Smoking, eating, vaping, and dabbing are the most common routes of marijuana use, according to research published in the April 10 issue of the U.S...

Hospital Addiction Consultation Service Aids Opioid Use Disorder

WEDNESDAY, April 16, 2025 -- A hospital-based addiction consultation service can improve receipt of evidence-based treatment for people with opioid use disorder (OUD), according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.